Literature DB >> 26261580

Spatial and temporal differences of HMGB1 expression in the pancreas of rats with acute pancreatitis.

Can Yu1, Lihua Huang2, Xia Li3, Hongwei Zhu1, Zhiqiang Li1, Xiao Yu1.   

Abstract

We aimed to investigate the spatial and temporal differences in expression between HMGB1 and early-stage inflammatory cytokines (IL-1, IL-6 and TNF-α) in pancreas tissue in rats with acute pancreatitis. SD rats (BW 350 ± 30 g, n = 48) were randomly divided into the experimental group (n = 36) which were injected with 5% sodium taurocholate into the bilipancreatic duct retrogradely to produce acute necrotic pancreatitis (ANP) rat models, and the sham-operated (SO) group (n = 12) injected with equal dose of saline. The rats were sacrificed at different time points at 0 h, 3 h, 6 h, 12 h, and 24 h post modeling, respectively. The peripheral blood amylase and different inflammatory factors in ANP rats at different time points were detected by ELISA, and the expression of HMGB1 in the pancreatic tissue was detected by immunohistochemistry, Western blot and Q-PCR methods. Results showed that the serum amylase in the ANP model rats was significantly higher than the sham-operated group (P < 0.05). The early inflammatory factors (IL-1, TNF-α and IL-6) increased quickly at 3 h after the model induction, reached the peak level at 6 h (higher than SO group, P < 0.05), then decreased at 12 h, and at 24 h the levels were lower than those at 12 h (P < 0.05). The HMGB1 level in the pancreatitis tissue did not change significantly at 3 h and 6 h (P > 0.05), however, it increased remarkably at 12 h, and maintained up to 24 h (P > 0.05). As a late inflammatory factor, the expression of HMGB1 in acute pancreatitis was obviously later than the early inflammatory factors IL-1, TNF-α and IL-6. HMGB1 may play a key role in maintaining the development of the acute pancreatitis.

Entities:  

Keywords:  Acute pancreatitis; HMGB1; early inflammatory factor

Mesh:

Substances:

Year:  2015        PMID: 26261580      PMCID: PMC4525914     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  13 in total

1.  Increase of high-mobility group box chromosomal protein 1 in blood and injured organs in experimental severe acute pancreatitis.

Authors:  Takeo Yasuda; Takashi Ueda; Makoto Shinzeki; Hidehiro Sawa; Takahiro Nakajima; Yoshifumi Takeyama; Yoshikazu Kuroda
Journal:  Pancreas       Date:  2007-05       Impact factor: 3.327

2.  Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis.

Authors:  Hidehiro Sawa; Takashi Ueda; Yoshifumi Takeyama; Takeo Yasuda; Makoto Shinzeki; Takahiro Nakajima; Yoshikazu Kuroda
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

Review 3.  IAP family proteins--suppressors of apoptosis.

Authors:  Q L Deveraux; J C Reed
Journal:  Genes Dev       Date:  1999-02-01       Impact factor: 11.361

4.  Antioxidant inhibits HMGB1 expression and reduces pancreas injury in rats with severe acute pancreatitis.

Authors:  Zhong Wei Zhang; Qi Yu Zhang; Meng Tao Zhou; Na Xin Liu; Tong Ke Chen; Ye Fan Zhu; Liang Wu
Journal:  Dig Dis Sci       Date:  2009-12-09       Impact factor: 3.199

Review 5.  Therapeutic potential of high mobility group box-1 in ischemic injury and tissue regeneration.

Authors:  Federico Biscetti; Giovanni Ghirlanda; Andrea Flex
Journal:  Curr Vasc Pharmacol       Date:  2011-11       Impact factor: 2.719

Review 6.  Molecular mechanisms of pancreatic injury.

Authors:  Raghuwansh P Sah; Ashok Saluja
Journal:  Curr Opin Gastroenterol       Date:  2011-09       Impact factor: 3.287

7.  Hyperbaric oxygen reduces inflammatory response in acute pancreatitis by inhibiting NF-kappaB activation.

Authors:  X Yu; Y G Li; X W He; X R Li; B N Din; Y Gan; M Xu
Journal:  Eur Surg Res       Date:  2009-01-28       Impact factor: 1.745

8.  Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis.

Authors:  Takeo Yasuda; Takashi Ueda; Yoshifumi Takeyama; Makoto Shinzeki; Hidehiro Sawa; Takahiro Nakajima; Tetsuo Ajiki; Yasuhiro Fujino; Yasuyuki Suzuki; Yoshikazu Kuroda
Journal:  Pancreas       Date:  2006-11       Impact factor: 3.327

9.  Plasma concentrations of high-mobility group box protein 1, soluble receptor for advanced glycation end-products and circulating DNA in patients with acute pancreatitis.

Authors:  A K Kocsis; A Szabolcs; P Hofner; T Takács; G Farkas; K Boda; Y Mándi
Journal:  Pancreatology       Date:  2009-05-19       Impact factor: 3.996

10.  Delayed ethyl pyruvate therapy attenuates experimental severe acute pancreatitis via reduced serum high mobility group box 1 levels in rats.

Authors:  Zhi-Yong Yang; Yan Ling; Tao Yin; Jing Tao; Jiong-Xin Xiong; He-Shui Wu; Chun-You Wang
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

View more
  4 in total

1.  Association between high mobility group box‑1 protein expression and cell death in acute pancreatitis.

Authors:  Enjun Gao; Yanfeng Jiang; Zhituo Li; Dongbo Xue; Weihui Zhang
Journal:  Mol Med Rep       Date:  2017-04-21       Impact factor: 2.952

Review 2.  Damage associated molecular patterns and neutrophil extracellular traps in acute pancreatitis.

Authors:  Xiaoying Zhou; Shengchun Jin; Jingyi Pan; Qingyi Lin; Shaopeng Yang; Peter C Ambe; Zarrin Basharat; Vincent Zimmer; Wei Wang; Wandong Hong
Journal:  Front Cell Infect Microbiol       Date:  2022-08-12       Impact factor: 6.073

3.  Effects of Toll‑like receptor 9 and CpG oligodeoxynucleotides 1826 on sodium taurocholate‑induced acute pancreatitis rats.

Authors:  Liang Sun; Yuanhua Li; Huayou Luo; Kunhua Wang; Li Li; Yujian Zeng
Journal:  Mol Med Rep       Date:  2018-08-03       Impact factor: 2.952

Review 4.  Comprehensive Mechanism, Novel Markers and Multidisciplinary Treatment of Severe Acute Pancreatitis-Associated Cardiac Injury - A Narrative Review.

Authors:  YaLan Luo; ZhaoXia Li; Peng Ge; HaoYa Guo; Lei Li; GuiXin Zhang; CaiMing Xu; HaiLong Chen
Journal:  J Inflamm Res       Date:  2021-07-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.